Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc. (MDGL) — Form 10-Q: Quarterly report
About this filing
Madrigal Pharmaceuticals Inc. (MDGL) filed Form 10-Q (quarterly report) with the SEC on Nov 3, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More MDGL filings
- SC 13D/A
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 6, 2026
- 8-K
Filed Nov 3, 2026
- 144
Filed Sep 28, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.